Haibo Cheng

1.6k total citations
79 papers, 1.1k citations indexed

About

Haibo Cheng is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Haibo Cheng has authored 79 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 18 papers in Oncology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Haibo Cheng's work include Pharmacological Effects of Natural Compounds (8 papers), Traditional Chinese Medicine Analysis (8 papers) and Flavonoids in Medical Research (6 papers). Haibo Cheng is often cited by papers focused on Pharmacological Effects of Natural Compounds (8 papers), Traditional Chinese Medicine Analysis (8 papers) and Flavonoids in Medical Research (6 papers). Haibo Cheng collaborates with scholars based in China, Macao and Hong Kong. Haibo Cheng's co-authors include Weixing Shen, Changliang Xu, Bin Yu, Ming Ruan, Jiani Tan, Dongdong Sun, Qibiao Wu, Xiao‐Ping Dong, Yun Yu and Xiqiao Zhou and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and Biomaterials.

In The Last Decade

Haibo Cheng

68 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haibo Cheng China 21 506 174 151 134 123 79 1.1k
Jian Hou China 25 764 1.5× 160 0.9× 177 1.2× 84 0.6× 108 0.9× 92 1.7k
Wesam M. El‐Bakly Egypt 15 329 0.7× 138 0.8× 137 0.9× 120 0.9× 123 1.0× 29 1.2k
Ling Tao China 23 541 1.1× 111 0.6× 220 1.5× 92 0.7× 99 0.8× 81 1.4k
Miwon Son South Korea 26 448 0.9× 164 0.9× 215 1.4× 77 0.6× 159 1.3× 78 1.7k
Nu‐Man Tsai Taiwan 22 671 1.3× 150 0.9× 78 0.5× 87 0.6× 116 0.9× 76 1.5k
Jianzhao Niu China 19 869 1.7× 290 1.7× 245 1.6× 125 0.9× 139 1.1× 60 1.9k
Yuan Du China 24 781 1.5× 99 0.6× 134 0.9× 70 0.5× 101 0.8× 68 1.5k
Amir R. Afshari Iran 25 753 1.5× 210 1.2× 190 1.3× 124 0.9× 164 1.3× 76 1.7k
Junzhe Zhang China 16 455 0.9× 129 0.7× 88 0.6× 136 1.0× 54 0.4× 53 1.0k
Xinhua Xia China 19 529 1.0× 84 0.5× 98 0.6× 94 0.7× 87 0.7× 62 1.1k

Countries citing papers authored by Haibo Cheng

Since Specialization
Citations

This map shows the geographic impact of Haibo Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haibo Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haibo Cheng more than expected).

Fields of papers citing papers by Haibo Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haibo Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haibo Cheng. The network helps show where Haibo Cheng may publish in the future.

Co-authorship network of co-authors of Haibo Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Haibo Cheng. A scholar is included among the top collaborators of Haibo Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haibo Cheng. Haibo Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wang, Jin, et al.. (2025). α-hederin decreases the glycolysis level in intestinal epithelial cells via SNX10-mediated DEPDC5 degradation. Journal of Pharmaceutical Analysis. 15(12). 101301–101301.
6.
Zhang, Y., Meng Shen, Jie Jin, et al.. (2025). Shen-Bai-Jie-Du decoction inhibits colorectal tumorigenesis by attenuating the malignancy of cancer stem cells via the gut microbiota-bile acid-FXR axis. Phytomedicine. 148. 157366–157366. 1 indexed citations
7.
Yang, Xueying, Zhiyu Li, Qianyu Wang, et al.. (2025). Huangqi Guizhi Wuwu decoction alleviate Oxaliplatin-Induced Peripheral Neuropathy by adjusting the myelin regeneration. Phytomedicine. 145. 157039–157039.
8.
Liu, Shaopeng, Qiang Zhang, Ping Ma, et al.. (2025). Prediction of herbal compatibility for colorectal adenoma treatment based on graph neural networks. Chinese Medicine. 20(1). 31–31. 3 indexed citations
9.
Hou, Dahai, Liu Li, Weixing Shen, et al.. (2024). Curcumol promotes ferroptosis of colon cancer by targeting the ubiquitination and degradation of GPX4. Journal of Traditional and Complementary Medicine. 15(2). 170–181. 2 indexed citations
10.
Li, Ziwen, Yueyang Lai, Jianrong Liu, et al.. (2024). α‐Hederin induces paraptosis by targeting GPCRs to activate Ca2+/MAPK signaling pathway in colorectal cancer. Cancer Medicine. 13(8). e7202–e7202. 10 indexed citations
11.
Lai, Yueyang, et al.. (2024). Single-cell transcriptomics and Mendelian randomization reveal LUCAT1’s role in right-sided colorectal cancer risk. Frontiers in Genetics. 15. 1357704–1357704.
12.
Liu, Lifen, et al.. (2024). A review on the pathogenesis theory of cancerous toxin from the viewpoint of system theory. SHILAP Revista de lepidopterología. 2(3). 187–193. 6 indexed citations
14.
Tan, Jiani, Qijuan Wang, Tingting Zhou, et al.. (2023). α-hederin regulates glucose metabolism in intestinal epithelial cells by increasing SNX10 expression. Phytomedicine. 111. 154677–154677. 3 indexed citations
15.
Sun, Xiaohe, Shuai Chen, Guowei Zhou, & Haibo Cheng. (2023). Association between the dietary inflammatory index and all-cause mortality in the U.S. cancer survivors: A prospective cohort study using the National Health and Nutrition Examination Survey database. Preventive Medicine Reports. 37. 102582–102582. 4 indexed citations
16.
Yu, Chengtao, Wenlong Hu, Dongdong Sun, et al.. (2022). Identification of Significant Modules and Targets of Xian-Lian-Jie-Du Decoction Based on the Analysis of Transcriptomics, Proteomics and Single-Cell Transcriptomics in Colorectal Tumor. SHILAP Revista de lepidopterología. 18 indexed citations
17.
Sun, Dongdong, Feng Zhang, Jie Qian, et al.. (2018). 4′-hydroxywogonin inhibits colorectal cancer angiogenesis by disrupting PI3K/AKT signaling. Chemico-Biological Interactions. 296. 26–33. 21 indexed citations
18.
Cheng, Haibo, Yanan Gao, Bo Zhu, et al.. (2018). β-Elemene Synergizes With Gefitinib to Inhibit Stem-Like Phenotypes and Progression of Lung Cancer via Down-Regulating EZH2. Frontiers in Pharmacology. 9. 1413–1413. 36 indexed citations
19.
Wu, Li, et al.. (2018). Effects of Dahuang zhechong pill on doxorubicin-resistant SMMC-7721 xenografts in mice. Journal of Ethnopharmacology. 222. 71–78. 22 indexed citations
20.
Chen, Zhipeng, Yang Song, Jiayu He, et al.. (2015). Hierarchical targeted hepatocyte mitochondrial multifunctional chitosan nanoparticles for anticancer drug delivery. Biomaterials. 52. 240–250. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026